HMS Hires Robert P. Borchert as New Investor Relations Officer
January 04 2019 - 8:00AM
HMS Holdings Corp (Nasdaq:HMSY) today announced that Robert P.
Borchert has joined the Company as Senior Vice President, Investor
Relations. He succeeds Dennis Oakes, who is retiring after more
than four years in the role.
Borchert comes to HMS with over 25 years of financial and
corporate communications experience, as well as extensive
healthcare technology and services industry expertise. He joins HMS
from MiMedx Group, a biopharmaceutical company developing,
manufacturing and marketing regenerative biologics. He served
previously as the investor relations officer at The Advisory Board
Company, a provider of healthcare research, software and consulting
services and at MedAssets, a provider of cost, process and payment
solutions to healthcare providers.
“Robert is a seasoned investor relations professional with an
extensive healthcare background. His deep industry knowledge, broad
corporate communications expertise and extensive experience with
the investment community make Robert an ideal addition to the HMS
team. We look forward to working with him to expand and further
develop our relations with investors, analysts and the broader
financial markets,” said Bill Lucia, Chairman and CEO. “I want to
thank Dennis Oakes for his important contributions since joining
HMS in 2014. He has very effectively helped message our growth
story, while fostering strong working relationships with both
investors and analysts,” added Lucia.
As an IR Magazine finalist for Best IR Officer and for Best
Overall Investor Relations, Borchert has been recognized for
outstanding investor relations work by his peers. At HMS, Borchert
will lead all investor and financial communications activities,
including: broadening awareness among institutional and other
investors and educating current and prospective investors about the
Company’s business strategy, performance and outlook. He has a BBA
in Marketing and Finance from Pace University and will be based in
the HMS corporate headquarters in Irving, Texas.
“I am excited to be joining HMS to support our leadership team
in raising awareness of our industry-leading healthcare
technology, analytics and engagement solutions that help reduce
costs and improve health outcomes,” Borchert said.
Oakes will continue in a consulting role for a period of time,
in order to ensure an orderly transition.
About HMS HMS advances the healthcare system by
helping payers reduce costs and improve health outcomes. Through
our industry-leading technology, analytics and engagement
solutions, we save billions of dollars annually while helping
health plan members lead healthier lives. HMS provides a broad
range of coordination of benefits, payment integrity, population
risk analytics, care management and consumer engagement solutions
that help move the healthcare system forward. Visit us
at www.hms.com or follow us on Twitter
at @HMSHealthcare.
Investor Contact: |
|
Media Contact: |
|
|
Robert P.
BorchertSVP, Investor
Relationsrobert.borchert@hms.com972-284-2140 |
|
Lacey
HautzingerSr. Director, External
Communicationslacey.hautzinger@hms.com469-284-7240 |
|
|
|
|
|
|
|
HMS (NASDAQ:HMSY)
Historical Stock Chart
From Jun 2024 to Jul 2024
HMS (NASDAQ:HMSY)
Historical Stock Chart
From Jul 2023 to Jul 2024